| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Mar 15, 2024 | Option Exercise | $5.30 | 2,967 | 15,740 | 176,761 | Mar 19, 2024, 06:45 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Mar 18, 2024 | Sale | $5.04 | 9,211 | 46,446 | 167,550 | Mar 19, 2024, 06:45 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Dec 31, 2023 | Option Exercise | $7.47 | 264 | 1,972 | 157,618 | Jan 03, 2024, 04:50 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Dec 15, 2023 | Option Exercise | $8.08 | 4,712 | 38,073 | 157,354 | Dec 18, 2023, 04:32 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Aug 11, 2023 | Option Exercise | $18.91 | 8,901 | 168,318 | 162,066 | Aug 15, 2023, 04:15 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Jun 30, 2023 | Option Exercise | $15.61 | 1,000 | 15,606 | 148,347 | Jul 05, 2023, 09:11 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Jun 09, 2023 | Sale | $30.82 | 5,000 | 154,096 | 147,347 | Jun 13, 2023, 08:09 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | May 15, 2023 | Sale | $34.55 | 21,015 | 726,003 | 152,347 | May 16, 2023, 08:29 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Mar 15, 2023 | Option Exercise | $30.65 | 2,967 | 90,939 | 120,967 | Mar 17, 2023, 03:21 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Mar 09, 2023 | Sale | $31.59 | 21,508 | 679,358 | 123,934 | Mar 09, 2023, 09:45 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Feb 15, 2023 | Option Exercise | $33.21 | 2,766 | 91,859 | 93,046 | Feb 16, 2023, 08:29 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Dec 31, 2022 | Option Exercise | $12.18 | 605 | 7,369 | 95,812 | Jan 03, 2023, 04:28 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Dec 15, 2022 | Option Exercise | $21.50 | 2,916 | 62,694 | 95,207 | Dec 16, 2022, 04:11 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Jun 30, 2022 | Option Exercise | $11.75 | 1,000 | 11,747 | 98,123 | Jul 05, 2022, 06:15 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Mar 15, 2022 | Option Exercise | $15.79 | 1,835 | 28,975 | 97,123 | Mar 17, 2022, 05:43 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Feb 15, 2022 | Option Exercise | $13.35 | 2,429 | 32,427 | 99,253 | Feb 17, 2022, 08:54 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | Dec 15, 2021 | Option Exercise | $15.92 | 513 | 8,167 | 101,387 | Dec 17, 2021, 05:29 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Jun 30, 2021 | Option Exercise | $24.09 | 882 | 21,246 | 65,980 | Jul 02, 2021, 07:56 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Apr 15, 2021 | Option Exercise | $28.16 | 411 | 11,574 | 65,098 | Apr 16, 2021, 08:17 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Feb 15, 2021 | Option Exercise | $28.97 | 2,410 | 69,818 | 67,644 | Feb 19, 2021, 08:13 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Dec 31, 2020 | Option Exercise | $21.36 | 348 | 7,433 | 45,299 | Jan 04, 2021, 07:59 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Dec 15, 2020 | Option Exercise | $26.75 | 562 | 15,034 | 44,951 | Dec 22, 2020, 08:37 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Sep 30, 2020 | Option Exercise | $25.14 | 6,051 | 152,122 | 45,513 | Oct 02, 2020, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Jun 30, 2020 | Option Exercise | $13.80 | 1,000 | 13,795 | 34,064 | Jul 02, 2020, 08:20 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Apr 15, 2020 | Option Exercise | $14.80 | 432 | 6,394 | 33,064 | Apr 17, 2020, 07:51 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Feb 15, 2020 | Option Exercise | $25.33 | 288 | 7,295 | 33,496 | Feb 19, 2020, 08:20 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Dec 31, 2019 | Option Exercise | $10.82 | 382 | 4,133 | 13,784 | Jan 03, 2020, 06:48 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Dec 15, 2019 | Option Exercise | $15.99 | 576 | 9,210 | 11,492 | Dec 17, 2019, 08:00 PM |
Menu